ClinicalTrials.Veeva

Menu

Evaluation of Proposed EZ2go Complete Bowel Cleansing System

B

Borland-Groover Clinic

Status

Completed

Conditions

Surveillance Colonoscopy
Screening Colonoscopy
Colonoscopy

Treatments

Other: LoSo Prep
Other: Ez2go Complete

Study type

Interventional

Funder types

Other

Identifiers

NCT01838408
Pro00008184

Details and patient eligibility

About

This study aims to provide safety and efficacy data comparable to available over-the-counter bowel preparations prior to colonoscopy. While there are many bowel preparations available, most of them remain expensive and require prescription from a health provider. The investigators believe EZ2go Complete will provide a non-inferior colon cleansing in a more accessible way (over-the-counter).

To accomplish this goal, the investigators decided to evaluate the proposed EZ2go combination versus currently available over-the-counter bowel preparations. The investigators believe the EZ2go kit will not be inferior to current FDA approved over-the-counter bowel preparations.

Enrollment

185 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients referred for routine colorectal cancer screening or surveillance colonoscopy examinations.
  • Male and Female participants 18 years of age and older.
  • Female participants who are not pregnant or planning to become pregnant within the next 90 days, or are sterile or of non-childbearing potential.
  • Negative urine test at the screening visit.
  • Subject is able to read and understand the informed consent form and signs the informed consent form.

Exclusion criteria

  • Contraindication to any of the bowel preparations being used in the study.
  • Unable/unwilling to fill out patient questionnaires following procedure.
  • Pregnant or lactating.
  • Unwilling to perform indicated lab work.
  • Lab results that would indicate stage 4-5 chronic kidney disease (GFR <30MI/min1.73 m2).
  • Personal history of colorectal cancer.
  • Personal history of colorectal or small bowel surgery.
  • Participants have any condition that, in the investigators opinion, could interfere with the participation and completion of this study.

Trial design

185 participants in 2 patient groups

EZ2go Complete
Experimental group
Description:
EZ2go complete: Peg 3350, Magnesium Citrate and Simethicone
Treatment:
Other: Ez2go Complete
LoSo Prep ™
Active Comparator group
Description:
LoSo Prep ™: Magnesium citrate and Bisacodyl
Treatment:
Other: LoSo Prep

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems